FDA Briefing Docs Offer Positives and Negatives for Sarepta (SRPT) - Baird
Go back to FDA Briefing Docs Offer Positives and Negatives for Sarepta (SRPT) - Baird| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 63.94 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.94 | 52 Week High | $108.96 | |||
| Open | $63.94 | 52 Week Low | $62.12 | |||
| Day High | $63.94 | P/E | N/A | |||
| Day Low | $63.94 | EPS | $-1.27 | |||
| Volume | 8,435 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 20.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.11 | 52 Week High | $63.73 | |||
| Open | $20.11 | 52 Week Low | $8.00 | |||
| Day High | $20.11 | P/E | N/A | |||
| Day Low | $20.11 | EPS | $-5.69 | |||
| Volume | 174 | |||||
